Clinical Trials Browser

Phase 2 × Giant Cell Tumor of Bone × Denosumab × Clear all

NCT00396279 2022-11-08

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Phase 2 Completed

37 enrolled 13 charts

Giant Cell Tumor of Bone

NCT00680992 2022-09-22

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Phase 2 Completed

535 enrolled 16 charts

Giant Cell Tumors, Neoplasms, Giant Cell Tumor of Bone

NCT03620149 2021-01-06

REDUCE

Phase 2 Terminated

Giant Cell Tumor of Bone